海鸥药房最新医药资讯列表-海鸥药房网

Current Location：Home>Medical Information

FDA Approves 177Lu-PSMA-617 for Pretreated PSMA+ Metastatic Castration-Resistant Prostate Cancer
2022-03-24 10:16:03
Based on data from the phase 3 VISION trial, 177Lu-PSMA-617 may now be used to treat patients who were previously treated with androgen receptor ...
Adjuvant CDK4/6 Inhibitors Demonstrate Success in Early-Stage HR+ Breast Cancer Development
2022-03-08 17:12:53
CDK4/6 inhibitors in the metastatic setting have demonstrated clinical benefit in the hormone receptor–positive breast cancer population, leading...
Sacituzumab Govitecan Significantly Improves PFS Vs Chemo in HR+ Metastatic Breast Cancer
2022-03-08 16:21:30
Sacituzumab govitecan resulted in a statistically significant improvement in progression-free survival vs physician’s choice of chemotherapy in p...
Frontline Poziotinib Produces Clinically Meaningful Efficacy in NSCLC Harboring HER2 Exon 20 Insertion Mutations
2022-03-08 15:59:29
Poziotinib elicited encouraging responses when given at a daily dose of 16 mg in the first-line treatment of patients with non–small cell lun...
Tamoxifen Plus Extended Letrozole Improves DFS in Postmenopausal Breast Cancer
2022-03-08 15:56:50
Initial treatment with tamoxifen (Soltamox) and letrozole for 2 to 3 years plus 5 years of extended treatment with letrozole appears to incre...
Ivosidenib/Azacitidine Granted Priority Review Designation by FDA for IDH1+ AML
2022-03-08 13:46:43
A supplemental new drug application for ivosidenib plus azacitidine was granted priority review by the FDA for previously untreated patients with...
Adjuvant Pembrolizumab Improves Distant Metastasis–Free Survival in Resected Stage IIB and IIC Melanoma
2022-03-08 13:46:39
Pembrolizumab significantly improved distant metastasis–free survival vs placebo when used as an adjuvant treatment in patients with resected sta...
First-ever malaria vaccine recommendation now published in a position paper and in the WHO guidelines for malaria
2022-03-07 17:47:17
WHO today published anupdated position paperon the RTS,S/AS01 (RTS,S) malaria vaccine that includes theOctober 2021 recommendationcalling for the...
Risk-Adaptive Approaches Offer Safer, Effective Strategies for Early-Stage HER2+ Breast Cancer
2022-03-07 17:21:14
The integration of HER2-targeted therapies into the treatment paradigm for patients with early-stage breast cancer, specifically the standard...
Employers Highlight Barriers to Biosimilar Adoption
2022-03-07 17:15:29
The promise of large savings due to the use of biosimilars has been stymied by barriers to adoption; however, there are actions employers can...

<<
<
1
2
3
>
>>
Jump to Page